WallStSmart

Rubrik, Inc. (RBRK)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Rubrik, Inc. generates 408% more annual revenue ($1.32B vs $258.90M). ZEPP leads profitability with a -15.5% profit margin vs -26.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

RBRK

Avoid

32

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: -2.56

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

RBRKSignificantly Overvalued (-45.5%)

Margin of Safety

-45.5%

Fair Value

$37.87

Current Price

$53.18

$15.31 premium

UndervaluedFair: $37.87Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RBRK2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
46.3%10/10

Revenue surging 46.3% year-over-year

Debt/EquityHealth
-2.1510/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

RBRK4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Altman Z-ScoreHealth
-2.562/10

Distress zone — elevated risk

Profit MarginProfitability
-26.5%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : RBRK

The strongest argument for RBRK centers on Revenue Growth, Debt/Equity. Revenue growth of 46.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : RBRK

The primary concerns for RBRK are EPS Growth, Return on Equity, Altman Z-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

RBRK is growing revenue faster at 46.3% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 32/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Rubrik, Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Rubrik, Inc. is a pioneering leader in the data management and cloud data control sector, offering cutting-edge enterprise data protection and recovery solutions. The company's robust platform integrates advanced technologies such as machine learning and artificial intelligence to streamline data backup, recovery, and archival across diverse multi-cloud environments. With a commitment to enhancing security and operational efficiency, Rubrik serves a wide range of clients, including large enterprises and government entities, positioning itself adeptly to manage the complexities of data lifecycle management. Amid the growing demand for resilient data solutions, Rubrik is strategically positioned for sustained growth and market leadership in an evolving digital landscape.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?